This course is free for qualified workplaces if your work email is on the list.
Click here to find out how to access the courses for free.
This module promotes the safe management of insulin, a commonly used high risk medicine.
On completion of this module you will be able to:
This module focuses on the use of subcutaneous insulin, with intravenous insulin falling outside its scope.
It is recommended that all clinicians who are involved with intravenous insulin review their state or local health service policies and clarify any ambiguities with their diabetes service.
Unlike subcutaneous insulin, the indications for the use of intravenous insulin do not only include hyperglycaemia. The specific equipment, procedures, clinical targets, monitoring and therapeutic endpoints do not fall within the scope of this module to address the associated risks and potential errors that can occur.
This module is intended for all health care staff involved in the management of insulin particularly in hospital, aged care and home care settings.
The module is designed to take around an hour to complete.
On successful completion of the assessments you can download a certificate of completion.
This module aligns with the National Safety and Quality Health Service Standards, Second Edition – Standards 1, 2, 4 & 6.
This module content was developed by the Australian Commission on Safety and Quality in Health Care and is protected by copyright under a Creative Commons Attribution-Non-Commercial-Share Alike (BY-NC-ND) 4.0 International License.
The content is provided in good faith by the Commission for information purposes. It is not a substitute for, and is not intended to replace, any specific policies, guidelines or requirements for your local health network or health service.
The Commission does not accept any legal liability or responsibility for any injury, loss or damage incurred by the use of, or reliance on, this information.
Date | |
---|---|
March 2025 | Updated to include new case studies and changes to current practice, policies and standards. |
March 2015 | First released. |
High concentration insulin products
Other resources
Manufacturers instructions
Other sites
National Subcutaneous Insulin Medication Charts
Other resources
User-applied labelling of injectable medicines, fluids and lines
Managing hypoglycaemia and hypoglycaemia
Other resources and references
Michelle Robins, Nurse Practitioner Diabetes, Northern Health, Melbourne.
Northern Health Insulin Working Group.